Impact of HER2 Expression on the Prognosis of Muscle-Invasive Bladder Cancer Patients Treated with Bladder-Preservation Comprehensive Therapy
This study confirms that cTURBT combined with RC48-ADC treatment for HER2-positive MIBC is superior to combined GC treatment in terms of RFS and OS, representing an effective treatment regimen for bladder preservation in MIBC patients.
Authors
- Yatong Chen
- Jian Li (ORCID: https://orcid.org/0000-0002-0835-8782)
- Fei Luo
- T. Zhang
Institutions
- Union Hospital (HK)
- Nankai University (CN)
- Tianjin First Center Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Biological Procedures Online
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1186/s12575-025-00261-w
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01